| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |